FDA Authorizes Marketing of 22nd Century Group's VLN® as a Modified Risk Tobacco Product

Retrieved on: 2021-12-24 13:00:08

Tags for this article:

Click the tags to see associated articles and topics

FDA Authorizes Marketing of 22nd Century Group's VLN® as a Modified Risk Tobacco Product. View article details on hiswai:

Excerpt

VLN® 95% Reduced Nicotine Content Cigarettes to Launch in the U.S. Within 90 Days · VLN® to Launch Outside the U.S. in First Quarter 2022.

Article found on: financialpost.com